Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227

Ming-Yao Chen,Vijesh Kumar Yadav,Yi Cheng Chu,Jiann Ruey Ong,Ting-Yi Huang,Kwai-Fong Lee,Kuen-Haur Lee,Chi-Tai Yeh,Wei-Hwa Lee

DOI: https://doi.org/10.3390/cancers15041028

2023-02-06

Abstract:Error in Figure [...].

What problem does this paper attempt to address?

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Wenxing Chen,Yanhong Pan,Siliang Wang,Yuping Liu,Guangying Chen,Liang Zhou,Chao Zhang,Wenting Ni,Aiyun Wang,Yin Lu,Shile Huang

DOI: https://doi.org/10.1186/s12885-019-5458-y

IF: 4.638

2019-01-01

BMC Cancer

Abstract:Following publication of the original article [1], the author noticed the following errors in the article.
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth.

Lu Zheng,Ping Liang,Jing Li,Xiao-Bing Huang,Shi-Cheng Liu,Hong-Zhi Zhao,Ke-Qiang Han,Zheng Wang

DOI: https://doi.org/10.1371/journal.pone.0214259

IF: 3.7

2019-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0045412.].
Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes (Oncotarget (2016) 7 (26966-26978) DOI: 10.18632/oncotarget.9034)

Junjie Gao,Tak Sum Cheng,An Qin,Nathan J. Pavlos,Tao Wang,Kai Song,Yan Wang,Lianzhi Chen,Lin Zhou,Qing Jiang,Hiroshi Takayanagi,Sheng Yan,Minghao Zheng

DOI: https://doi.org/10.18632/oncotarget.27035

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.9034.].
Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs

Feng Chen,Huihui Wang,Jiayu Zhu,Rui Zhao,Peng Xue,Qiang Zhang,M Bud Nelson,Weidong Qu,Bo Feng,Jingbo Pi

DOI: https://doi.org/10.1038/s41416-019-0527-1

IF: 9.075

2019-01-01

British Journal of Cancer

Abstract:The original version of this article contained an error in Figure 6A. The volumes of the tumour xenografts were incorrectly calculated. The correct figure and figure legend are provided, where the volume has been calculated using V = length × width2×π/6. The interpretation of the data and conclusions are not affected.
Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Lei Qian,Nanya Wang,Huimin Tian,Haofan Jin,Hengjun Zhao,Chao Niu,Hua He,Tingwen Ge,Wei Han,Jifan Hu,Dan Li,Fujun Han,Jianting Xu,Xiao Ding,Jingtao Chen,Wei Li,Jiuwei Cui

DOI: https://doi.org/10.1155/2022/9761463

IF: 4.4929

2022-07-18

Journal of Immunology Research

Abstract:In the article titled "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients" [1], the authors wish to correct Figure 2. Due to an oversight when preparing the manuscript, it is duplicated with Figure 3 in a previous publication by the authors [2]. These two studies were related, and the data were saved to the same location, contributing to the erroneous selection of the image for publication. The authors apologise for this error and provide the corrected Figure 2 as follows:

immunology
Correction To: PHF8 Upregulation Contributes to Autophagic Degradation of E-cadherin, Epithelial-Mesenchymal Transition and Metastasis in Hepatocellular Carcinoma

Wuhua Zhou,Likun Gong,Qinchuan Wu,Chunyang Xing,Bajin Wei,Tianchi Chen,Yuan Zhou,Shengyong Yin,Bin Jiang,Haiyang Xie,Lin Zhou,Shusen Zheng

DOI: https://doi.org/10.1186/s13046-019-1452-0

IF: 12.658

2019-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:In the publication of our publication [1], we have noticed there is a wrong label in Fig. 1e, in which the position of “HCC” and “Adjacent” should be transposed.
Correction: Corrigendum: Patient-specific Hepatocyte-Like Cells Derived from Induced Pluripotent Stem Cells Model Pazopanib-Mediated Hepatotoxicity

Yukti Choudhury,Yi‐Chin Toh,Jiangwa Xing,Yinghua Qu,Jonathan Poh,Huan Li,Hui Shan Tan,Ravindran Kanesvaran,Hanry Yu,Min‐Han Tan

DOI: https://doi.org/10.1038/srep46391

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 7: Article number: 41238; published online: 25 January 2017; updated: 25 April 2017 The original version of this Article contained an error in the spelling of the author Huan Li, which was incorrectly given as Li Huan. The Author Contributions Statement, Study concept and design: Y.
Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Yuanyuan Chen,Hui Zhong,Jianbo Wang,Xiuyan Wan,Yanhua Li,Wei Pan,Na Li,Bo Tang

DOI: https://doi.org/10.1039/d0sc90108c

IF: 8.4

2020-01-01

Chemical Science

Abstract:Correction for ‘Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence’ by Yuanyuan Chen et al., Chem. Sci., 2019, 10, 5773–5778, DOI: 10.1039/C9SC00747D.
Correction: MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET–SOCS1–MMP9 signaling axis

Qing Chen,Dan Yin,Yong Zhang,Lei Yu,Xue-Dong Li,Zheng-Jun Zhou,Shao-Lai Zhou,Dong-Mei Gao,Jie Hu,Cheng Jin,Zheng Wang,Ying-Hong Shi,Ya Cao,Jia Fan,Zhi Dai,Jian Zhou

DOI: https://doi.org/10.1038/s41419-024-07144-0

2024-11-19

Cell Death and Disease

Abstract:Cell Death & Disease, Published online: 14 November 2024; doi:10.1038/s41419-024-07144-0 Correction: MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET–SOCS1–MMP9 signaling axis

cell biology
Correction: Chao Et Al. MicroRNA-22-3p and MicroRNA-149-5p Inhibit Human Hepatocellular Carcinoma Cell Growth and Metastasis Properties by Regulating Methylenetetrahydrofolate Reductase. Curr. Issues Mol. Biol. 2022, 44, 952–962

Chao Li,Xiang Li,Han Wang,Xihan Guo,Jinglun Xue,Xu Wang,Juan Ni

DOI: https://doi.org/10.3390/cimb46090630

2024-01-01

Current Issues in Molecular Biology

Abstract:Author Correction: We apologize for unintentionally using the wrong figures (Figure 5b and Figure 6e) in the original article [...]
Correction To: Minichromosome Maintenance 3 Promotes Hepatocellular Carcinoma Radioresistance by Activating the NF-κB Pathway.

Qing Yang,Binhui Xie,Hui Tang,Wei Meng,Changchang Jia,Xiaomei Zhang,Yi Zhang,Jianwen Zhang,Heping Li,Binsheng Fu

DOI: https://doi.org/10.1186/s13046-019-1338-1

2019-01-01

Abstract:In the original publication of this article [1], the authors reported the order of the authors was incorrect and needs to be revised. The original article has been updated to rectify this error.
Correction: Cheng et al. Glutathione S-Transferases S1, Z1 and A1 Serve as Prognostic Factors in Glioblastoma and Promote Drug Resistance through Antioxidant Pathways. Cells 2022, 11, 3232

Bo Cheng,Yu Wang,Abiola Abdulrahman Ayanlaja,Jing Zhu,Piniel Alphayo Kambey,Ziqiang Qiu,Caiyi Zhang,Wei Hu

DOI: https://doi.org/10.3390/cells12141908

IF: 6

2023-07-22

Cells

Abstract:Cells, Vol. 12, Pages 1908: Correction: Cheng et al. Glutathione S-Transferases S1, Z1 and A1 Serve as Prognostic Factors in Glioblastoma and Promote Drug Resistance through Antioxidant Pathways. Cells 2022, 11, 3232 Cells doi: 10.3390/cells12141908 Authors: Bo Cheng Yu Wang Abiola Abdulrahman Ayanlaja Jing Zhu Piniel Alphayo Kambey Ziqiang Qiu Caiyi Zhang Wei Hu The authors wish to make the following change to their paper [...]

cell biology
[Corrigendum] The cranberry flavonoids PAC DP‑9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells

Yifei Wang,Alex Han,Eva Chen,Rakesh K Singh,Clinton O Chichester,Richard G Moore,Ajay P Singh,Nicholi Vorsa

DOI: https://doi.org/10.3892/ijo.2022.5408

Abstract:Following the publication of this article, an interested reader drew to the author's attention that, in Fig. 5D on p. 1931, the two rightmost panels appeared to have been inverted for the SKOV3 cell line (i.e., the 'Q‑aglycone' and 'PAC DP‑9' data panels appeared to have been included in this figure the wrong way around). The authors checked the figure, and realized that these panels had indeed erroneously been inverted during the assembly of the figure. The corrected version of Fig. 5 is shown on the next page. The authors regret that this error was not picked up upon before the paper was sent to press, and thank the Editor of International Journal of Oncology for allowing them the opportunity to publish this corrigendum. Furthermore, they regret any inconvenience caused to the readership. [International Journal of Oncology 46: 1924‑1934, 2015; DOI: 10.3892/ijo.2015.2931].
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Xiwei Ding,Yiyang Zhang,Tianlu Huang,Guifang Xu,Chunyan Peng,Gang Chen,Bo Kong,Helmut Friess,Shanshan Shen,Ying Lv,Lewis R Roberts,Lei Wang,Xiaoping Zou

2023-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 546 in vol. 9, PMID: 30949409.].
Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Dongli Yue,Daiqun Zhang,Xiaojuan Shi,Shasha Liu,Anqi Li,Dong Wang,Guohui Qin,Yu Ping,Yamin Qiao,Xinfeng Chen,Feng Wang,Renyin Chen,Song Zhao,Lidong Wang,Yi Zhang

DOI: https://doi.org/10.3389/fonc.2022.860158

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00311.].

oncology
Correction: Li et al. Selenomethionine Inhibited HADV-Induced Apoptosis Mediated by ROS through the JAK-STAT3 Signaling Pathway. Nutrients 2024, 16, 1966

Chuqing Li,Xia Liu,Jiali Li,Jia Lai,Jingyao Su,Bing Zhu,Buyun Gao,Yinghua Li,Mingqi Zhao

DOI: https://doi.org/10.3390/nu16172969

IF: 5.9

2024-09-04

Nutrients

Abstract:Nutrients, Vol. 16, Pages 2969: Correction: Li et al. Selenomethionine Inhibited HADV-Induced Apoptosis Mediated by ROS through the JAK-STAT3 Signaling Pathway. Nutrients 2024, 16, 1966 Nutrients doi: 10.3390/nu16172969 Authors: Chuqing Li Xia Liu Jiali Li Jia Lai Jingyao Su Bing Zhu Buyun Gao Yinghua Li Mingqi Zhao In the original publication [...]

nutrition & dietetics
Correction: Huang et al. Endogenous Propionibacterium acnes Promotes Ovarian Cancer Progression via Regulating Hedgehog Signalling Pathway. Cancers 2022, 14, 5178

Qifa Huang,Xin Wei,Wenyu Li,Yanbing Ma,Guanxiang Chen,Lu Zhao,Ying Jiang,Siqi Xie,Qi Chen,Tingtao Chen

DOI: https://doi.org/10.3390/cancers16183185

2024-09-19

Cancers

Abstract:Cancers, Vol. 16, Pages 3185: Correction: Huang et al. Endogenous Propionibacterium acnes Promotes Ovarian Cancer Progression via Regulating Hedgehog Signalling Pathway. Cancers 2022, 14, 5178 Cancers doi: 10.3390/cancers16183185 Authors: Qifa Huang Xin Wei Wenyu Li Yanbing Ma Guanxiang Chen Lu Zhao Ying Jiang Siqi Xie Qi Chen Tingtao Chen In the original publication [...]

oncology
Erratum To: Inhibition of Chemotherapy-Related Breast Tumor EMT by Application of Redox-Sensitive Sirna Delivery System CSO-ss-SA/siRNA along with Doxorubicin Treatment

Xuan Liu,Xueqing Zhou,Xuwei Shang,Li Wang,Yi Li,Hong Yuan,Fuqiang Hu

DOI: https://doi.org/10.1631/jzus.b19e0468

2022-01-01

Journal of Zhejiang University SCIENCE B

Abstract:The online version of the original article can be found at https://doi.org/10.1631/jzus.B1900468 The original version of this article (Liu et al., 2020) unfortunately contained some mistakes. 1. Figs. 7c and 7d in p.229 were incorrect. The upper left and bottom left pictures in Fig. 7c were accidentally duplicated with the pictures at the same position of Fig. 1a. The upper right and bottom right pictures were mistakenly placed in Fig. 7c. Therefore, the calculation results in Fig. 7d were also mistaken. The correct versions should be as follows: 2. Because of the wrong pictures of Fig. 7c, the calculated results of "42.5%" in Abstract, Sections 3.9 and 5 are also mistaken. The correct result should be "45.2%." (1) Lines 10-12 of Abstract in p.218: "CSO-ss-SA/siRNA could effectively transmit siRNA into tumor cells, reducing the expression of RAC1 protein by 38.2% and decreasing the number of tumor-induced invasion cells by 42.5%." was incorrect. The correct version should be "CSO-ss-SA/siRNA could effectively transmit siRNA into tumor cells, reducing the expression of RAC1 protein by 38.2% and decreasing the number of tumor-induced invasion cells by 45.2%." (2) Lines 23-26 of Section 3.9 in p.227: "It was shown that the number of invasive tumor cells induced by DOX was reduced by 42.5% since CSO-ss-SA/siRNA downregulated the expression of RAC1 protein." was incorrect. The correct version should be "It was shown that the number of invasive tumor cells induced by DOX was reduced by 45.2% since CSO-ss-SA/siRNA downregulated the expression of RAC1 protein." (3) Lines 4-8 of Section 5 in p.231: "CSO-ss-SA, as an efficient redox-sensitive carrier for delivering siRNA silencing RAC1 into tumor cells, reduced the expression of RAC1 by 38.2% and decreased DOX-induced tumor invasion cells by 42.5% in vitro." was incorrect. The correct version should be "CSO-ss-SA, as an efficient redox-sensitive carrier for delivering siRNA silencing RAC1 into tumor cells, reduced the expression of RAC1 by 38.2% and decreased DOX-induced tumor invasion cells by 45.2% in vitro."
Corrigendum To: "pkcα/zfp64/csf1 Axis Resets the Tumor Microenvironment and Fuels Anti-Pd1 Resistance in Hepatocellular Carcinoma" [J Hepatol 77 (2022) 163-176].

Chuan-Yuan Wei,Meng-Xuan Zhu,Peng-Fei Zhang,Xiao-Yong Huang,Jin-Kai Wan,Xiu-Zhong Yao,Ze-Tao Hu,Xiao-Qiang Chai,Rui Peng,Xuan Yang,Chao Gao,Jian Gao,Si-Wei Wang,Yi-Min Zheng,Zheng Tang,Qiang Gao,Jian Zhou,Jia-Bin Cai,Ai-Wu Ke,Jia Fan

DOI: https://doi.org/10.1016/j.jhep.2022.11.004

IF: 25.7

2023-01-01

Journal of Hepatology

Abstract:PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinomaJournal of HepatologyVol. 77Issue 1PreviewDespite remarkable advances in treatment, most patients with hepatocellular carcinoma (HCC) respond poorly to anti-programmed cell death 1 (anti-PD1) therapy. A deeper insight into the tolerance mechanism of HCC against this therapy is urgently needed. Full-Text PDF Open Access It has come to our attention that there are errors in the author list and Fig. 2C,D of our manuscript. In the author list, the name of the co-corresponding author ‘Jia-Bin Cai’ was misspelled ‘Jia-Bin Fan’. Please note that ‘Jia-Bin Cai’ is the correct spelling. In Fig. 2C,D, the occurrences of ‘ZPF6’ and ‘ZF1P6’ are typos and should all read ‘ZFP64’. A corrected version of Fig.2 is included below. We apologize for any inconvenience caused.

Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227

Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Correction: ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth.

Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes (Oncotarget (2016) 7 (26966-26978) DOI: 10.18632/oncotarget.9034)

Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs

Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

Correction To: PHF8 Upregulation Contributes to Autophagic Degradation of E-cadherin, Epithelial-Mesenchymal Transition and Metastasis in Hepatocellular Carcinoma

Correction: Corrigendum: Patient-specific Hepatocyte-Like Cells Derived from Induced Pluripotent Stem Cells Model Pazopanib-Mediated Hepatotoxicity

Correction: Catalase-like Metal–organic Framework Nanoparticles to Enhance Radiotherapy in Hypoxic Cancer and Prevent Cancer Recurrence

Correction: MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET–SOCS1–MMP9 signaling axis

Correction: Chao Et Al. MicroRNA-22-3p and MicroRNA-149-5p Inhibit Human Hepatocellular Carcinoma Cell Growth and Metastasis Properties by Regulating Methylenetetrahydrofolate Reductase. Curr. Issues Mol. Biol. 2022, 44, 952–962

Correction To: Minichromosome Maintenance 3 Promotes Hepatocellular Carcinoma Radioresistance by Activating the NF-κB Pathway.

Correction: Cheng et al. Glutathione S-Transferases S1, Z1 and A1 Serve as Prognostic Factors in Glioblastoma and Promote Drug Resistance through Antioxidant Pathways. Cells 2022, 11, 3232

[Corrigendum] The cranberry flavonoids PAC DP‑9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells

Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Correction: Li et al. Selenomethionine Inhibited HADV-Induced Apoptosis Mediated by ROS through the JAK-STAT3 Signaling Pathway. Nutrients 2024, 16, 1966

Correction: Huang et al. Endogenous Propionibacterium acnes Promotes Ovarian Cancer Progression via Regulating Hedgehog Signalling Pathway. Cancers 2022, 14, 5178

Erratum To: Inhibition of Chemotherapy-Related Breast Tumor EMT by Application of Redox-Sensitive Sirna Delivery System CSO-ss-SA/siRNA along with Doxorubicin Treatment

Corrigendum To: "pkcα/zfp64/csf1 Axis Resets the Tumor Microenvironment and Fuels Anti-Pd1 Resistance in Hepatocellular Carcinoma" [J Hepatol 77 (2022) 163-176].